Chris Senyek, Wolfe Research chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, ...

If Trump actually fires Powell, expect chaos. That’s the blunt warning from Wall Street analysts, legal professionals, and ...

Former deputy Treasury Secretary Roger Altman said he did not think Jerome Powell would agree to leave if the president asked ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...

Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...

Centene Corporation (NYSE:CNC) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 2, Wolfe ...

Shares of MongoDB (MDB) rose about 2% on Wednesday after Wolfe Research began coverage on the database software company with ...

Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...

Science Trump Is Gutting LGBTQ+ Research. It’s Going to Cost Us All. Everyone’s health is at stake.

N.I.H. Memo Pauses Cancellations of Medical Research Grants The directive, in a memo issued Tuesday, came after two court rulings that questioned the Trump administration’s swift cuts to funding.